Post on 12-Apr-2017
Investor PresentationFY 2015/16
1
Contents
2
1 Hemas Business : Revenue and Profitability by Sector
2 History and Milestones
3 Consolidated Group Performance for FY 2015/16
4 Consumer
5 Healthcare
6 Transportation
7 Leisure
8 Sustainability
9 Vision 2020
Hemas is a Wellness, Leisure and Mobility
Business with LKR 38 billion in revenues
3
Revenue
Segmental Revenue and Operating Profits, FY 2015/16
Operating Profit (Rs. Mn) FY 2015/16
Consumer 1,768
Healthcare 1,780
Leisure 255
Transportation 499
Other (342)
Total 3,960Consumer
38%
Healthcare42%
Leisure9%
Transportation 5%
Other6%
-500
0
500
1000
1500
2000
Consumer Healthcare Leisure Transportation Other
Op
era
tin
g P
rofit in
LK
R M
illio
ns
History and Milestones
4
201420132011
Entry into
Bangladesh
2007
Entered the
Hospital
business via
Acquisition
20031970s
Diversified into
travel &
tourism
1962
Entered the
Consumer
business
1948
Founded
Hemas
Drugs
Ltd.
Acquired J.L
Morison Son
& Jones
(Ceylon)
PLC
Exited
non-core
business
Hemas
Holdings
Listed on
CSE
Performance Indicator
(Rs. Mn)
FY
2015/16
FY
2014/15% Change
Group Revenue 37,978 32,497 16.9%
Operating Profit 3,961 3,371 17.5%
Profit After Tax 2.926 2,196 33.2%
Group Earnings 2.653 1,927 37.7%
Performance IndicatorFY
2015/16
FY
2014/15% Change
ROE 14.1% 12.9%
ROCE 16.8% 14.7%
EPS 4.63 3.74 23.9%
Net Assets per Share 38.41 30.39 26.3%
Share Price (Mar 31) 80.60 73.70 9.3%
Market Cap Rs. Mn (Mar 31) 46,147 37,977 21.5%
Consolidated revenues for FY 2015/16 was LKR 38 Bn, up
16.9% over the previous year, with Group Earnings up 37.7%
Growth coming primarily from strong performance in Consumer and Healthcare sectors.
Hemas Holdings PLC, FY 2015/16
• HHL recorded solid performance for FY 2015/16 with
consolidated Group of Rs. 38.0 Bn—a YoY growth of
16.9%.
• Operating profit reached Rs. 4.0 Bn and Earnings Rs.
2.7Bn, a growth of 17.5% and 37.7% respectively.
• Revenue growth was led by the strong performance of our
Consumer and Healthcare sectors and additional interest
income from the proceeds of the rights issue boosted
Earnings.
Segmental Earnings, FY 2015/16
5
-400
0
400
800
1,200
1,600
Consumer Healthcare Leisure Transportation Other
Rs. Millions
Consumer
6
Hemas Consumer is Sri Lanka’s largest domestic Personal
Care business, accounting for 38% of Group Revenues
Hair CareOral CareBaby Care
Feminine Hygiene Home CarePersonal Wash
7
Hemas entered Bangladesh in 2011, and today we are the
number two value-added hair oil brand with Kumarika
• Kumarika hair oil has 16% market share in the value added oil segment,
with 3-year revenue CAGR of 90%.
• 115,000 urban and rural retail outlets reached; distribution reach grown
15% annually.
• Operate own distribution, through a network of 140 distributors and over
100 sub-distributors.
• 280 sales reps operating in 21 territories.
• New product launched under “Kumarika” brand platform: two variants of
a science + nature face wash.
0
400
800
1,200
1,600
2,000
2010/11 2011/12 2012/13 2013/14 2014/15 2015/16
Bangladesh Revenue in Rs. Million2010/11–2015/16
8
Market leader in personal care, strong iconic brands with
international relevance
Revenues up by 20% YoY, driven by robust volume growth in personal wash, feminine hygiene and home care.
• Portfolio comprises personal care, personal wash and home care products.
• Market leader in baby care, hair oil, and beauty soap.
• Domestic distribution retail coverage of 80,000+.
• Introduced new Gel variants of Clogard along with mouth wash product range and Velvet soap variants “Water Lily & Sea Minerals”, “Honey and Yoghurt.”
• Fems, Clogard, Baby Cheramy and Diva brands posted double digit topline growth rates underpinning sector revenue growth.
Sector Highlights
• Consumer sector reported a total revenue of
Rs. 14.3Bn, a 20.2% YoY growth.
• Sector performance was driven by strong
performance of Bangladesh operation and sales
growth across all our major brands in the domestic
market, with relatively weak commodity prices for key
raw material inputs.
Financial Highlights
Consumer Revenue and Operating Profit
FY 2011/12–2015/16
Consumer Revenue Share, FY 2015/16
9
'-
350
700
1,050
1,400
1,750
2,100
'-
3,000
6,000
9,000
12,000
15,000
18,000
2011/12 2012/13 2013/14 2014/15 2015/16
Op
era
tin
g P
rofi
t -
Rs
. M
illi
on
Re
ve
nu
e -
Rs
. M
illio
n
Revenue Operating Profit
Consumer37.7%Rest of
Group62.3%
Healthcare
10
Hemas is the largest healthcare company in Sri Lanka
with interests in Pharmaceuticals, Hospitals and Diagnostics
Pharmaceutical
Distribution
Rx &
OTC
Pharmaceutical
Manufacturing
Hospitals &
Diagnostics
Network
11
In pharmaceutical distribution, Hemas represents the largest
global multinational pharmaceutical manufacturers
650Employees
35+Principals
9Therapeutic
Categories
22%Market Share 3000+
Pharmacies
12
Hemas
Pharmaceuticals
OTC Own Brands
• Lacto Calamine
• Gripe Mixture
• Baby Cough Syrup
• Valmelix Cough Syrup
JLM, acquired in 2013, is a market leading Rx manufacturer
with leading OTC brands
J.L. Morison Son & Jones
33%Earnings
CAGR since
acquisition
Rs. 000’ FY 2014 FY 2015 FY 2016
Revenue 2,638,931 3,025,969 3,714,848
Operating Profit 258,189 324,173 460,516
Earnings 210,757 247,091 351,179
Financial Highlights
13
• Manufactures over sixty formulations of high quality
pharmaceutical and OTC products.
• Import and distribution of internationally renowned products via
our island-wide distribution network.
• JLM signed a five year buy-back agreement with the Government
of Sri Lanka to provide essential medicines to the National
Healthcare system.
• JLM revenue and earnings for the year grew by 22.8% and
43.4% respectively supported by the growth of core segments,
improved efficiency and capacity gains at plant, and the strength
of a newly restructured distribution network.
Hemas is the first hospital chain to take high quality private
healthcare to rapidly growing Colombo suburbs
• 3 multi-specialty, ACHSI accredited hospitals built on international
standards in the North of Colombo, East of Colombo and in the
Southern Province.
• 3 additional laboratories opened this year; bring network up to 36
laboratories, serving over 500 physicians and addressing a patient
population of 5 million.
• Through our new corporate polyclinic model, we are locating in
large working population environments, with a continued focus on
bringing healthcare to the consumer.
14
Wattala 100 beds Thalawathugoda 60 beds Galle 50 beds
Healthcare42.5%Rest of Group
57.5%
Deep experience across healthcare value chain with market
leading positions in distribution and diagnostics
Sector Highlights
Financial Highlights
• Healthcare segment of the Group achieved sales of Rs.16.1Bn, a growth of 16.0%.
• 8% growth in Pharma distribution revenues indicates encouraging performance, during a period of significant regulatory change in the pharmaceutical industry.
• Increased demand for private healthcare and health seeking behavior growing demand for diagnostics, all three hospitals recorded a revenue growth of 31.9% YoY.
Healthcare Revenue and Operating Profit
FY 2011/12–2015/16
Healthcare Revenue Share, FY 2015/16
15
'-
325
650
975
1,300
1,625
1,950
'-
3,000
6,000
9,000
12,000
15,000
18,000
2011/12 2012/13 2013/14 2014/15 2015/16
Op
era
tin
g P
rofi
t -
Rs
. M
illi
on
Reve
nu
e -
Rs
. M
illi
on
Revenue Operating Profit• Hemas Hospitals opened its first wellness centre to
6,000 plus employees at Colombo’s premier IT park, Orion City.
• Wattala and Southern Hospitals were re-accredited by the ACHSI and Hemas Hospital Thalawathugodaobtained its 1st accreditation during the year.
• Pharmaceutical business grew Rx and OTC portfolio consistently, adding new principles.
• JLM’s buyback agreement and continued focus on distribution efficiency contributed to the growth in sales
Transportation
16
Travel and
AviationOutboundMaritimeLogistics
• Hemas offers complete passenger
and cargo solutions in Airline
Representation and travel related
services
• Hemas represents airlines
Emirates, Malaysia Airline and
Maldivian and other major airlines.
• Largest GSA operator in passenger
and cargo with a market share of
25% and 20%, respectively
• Grew Emirates airlines from 1 flight
per day to 7 flights per day
• 5th in the travel market
• Integrated portfolio of
container haulage, container
yard operations, warehousing,
automotive logistics and
transportation of project and
over-dimensional cargo.
• 6 acre container terminal.
• Maritime sector acts as a
shipping agent providing
agency services for our feeder
operator.
• Far Shipping Lines (FSL)
Singapore
• Operates the largest feeder
service to the Bay of Bengal
• Exclusive agent for ‘HC line’
and NVOCC operator ‘Asian
Tiger Shipping’
• Appointed General Agents for
Evergreen, the fourth largest
mainliner with revenues of
US$ 4 Bn.
• Award winning, IATA
accredited travel agency.
• Corporate travel service is a
network partner of HRG which
offers global travel services
and hotel reservations.
17
Through our Mobility arm, we are securing new accounts and
growing capacity in logistics, warehousing and haulage
Transportation4.7%
Rest of Group95.3%
Our Mobility business had LKR 1.8 billion in revenues for FY
2015/16, a year-on-year growth of 17%
Sector Highlights
Financial Highlights
• Transportation sector revenue of Rs.1.8 Bn reflects a YoY growth of 17.2%, stemming from strong performance of our domestic maritime and logistics business interests.
• Logistics business grew through new projects, with our warehouses operating with full capacity and haulage business growing with the car carrier operation.
• Aviation businesses continued to experience challenges due to lower yields of ticketing income.
• Operating profits grew at a slower rate of 8.2% when compared to the revenue growth rate, due to limited growth reflected in aviation.
Transportation Revenue and Operating Profit
FY 2011/12–2015/16
Transportation Revenue Share, FY 2015/16
18
'-
85
170
255
340
425
510
595
'-
325
650
975
1,300
1,625
1,950
2011/12 2012/13 2013/14 2014/15 2015/16
Op
era
tin
g P
rofi
t -
Rs
. M
illi
on
Re
ve
nu
e -
Rs
. M
illio
n
Revenue Operating Profit• Hemas Maritime appointed General Agents for
Evergreen Marine Corporation Taiwan, one of thelargest feeder carriers servicing the Port of Colombo.
• Strategic investments in logistics verticals providing integrated end to end solutions
• Good growth in Logistics 3PL business with increased volumes stemming from the container depot which functioned at its optimum level of efficiency.
Leisure
19
Our Leisure business comprises leading travel brands and an
inbound leisure business
• Serendib Leisure Group of Hotels which, includes four award winning
properties with a total inventory of 550 rooms.
• The partnership with Minor Hotel Group (MHG) has enabled Serendib Leisure
to be the only Sri Lankan hotel chain to manage an international brand,
“AVANI”.
Coming Soon
20
Leisure9.0%
Rest of Group91.0%
We are investing in Sri Lanka’s tourism boom with a selection of
new builds, targeting the upper star class segment of the market
YTD revenues of LKR 3.4Bn, with 13.0% increase year on year.
• Owner and Manager of ffive properties with a combined room inventory of 563.
• Strategic partnership with Minor Hotel Group, a leading Asian hotel chain
• During December 2016, we opened our newest hotel property, Anantara Peace Haven Tangalle Resort, this property will establish a new benchmark for luxury travellers to Sri Lanka seeking authentic cultural experiences.
• The hotels group revenue grew by 12.2% owing to the strong performance of AVANI Bentota and Hotel Sigiriya
• Diethelm Travels recorded a 21% growth in the inbound volume which resulted a 14% growth in the topline.
Sector Highlights
Financial Highlights
• Leisure segment recorded a total revenue of Rs. 3.4Bn for FY 2015/16, registering a 13.0% YoY increase.
• The increase was primarily driven by a good overall occupancy rate of 79%.
• The first few months of the new hotel Anantara Tangallehas been encouraging.
Leisure Revenue and Operating Profit
FY 2011/12–2015/16
Leisure Revenue Share, FY 2015/16
21
'-
65
130
195
260
325
390
455
520
585
'-
550
1,100
1,650
2,200
2,750
3,300
3,850
2011/12 2012/13 2013/14 2014/15 2015/16
Op
era
tin
g P
rofi
t -
Rs
. M
illi
on
Reve
nu
e -
Rs
. M
illi
on
Revenue Operating Profit
Sustainability
22
Enriching lives through the spirit of Abhimana
• Abhimana’ is our ethos of sustainability that
describes our vision of a sustainable and co-
operative society, of people living and working
together
• Inline with this, we have released our Sustainability
Report providing insight into the Group’s
sustainability philosophy and initiatives in line with
the Global Reporting Initiative G4 guidelines (GRI-
G4) : http://www.hemas.com/reports
• Today, our strategic path is governed not only by
how well we develop growing commercial
opportunities but also by listening to and
responding to the communities of which we are a
part.
23
Piyawara
• The Hemas ‘Piyawara’ project focuses on early
childhood care and development, penetrating the
segment by facilitating preschool education for
children aged 3 to 5 years, from marginalised
communities.
• With the mission “to nurture young children with
good care in order to provide a solid foundation of
a life long journey”
24
Vision 2020 - To be the best at enriching lives
• Delighting South Asian consumers with our high quality innovative personal care
solutions
• Providing excellent healthcare outcomes for all Sri Lankans
• Outstanding leisure experiences to the emerging traveler
• Driving exceptional mobility solutions for the travel and logistics needs of the nation
• While at all times operating true to Hemas Values and our ethos of Abhimana
25
2020
Vision
Thank You
CONFIDENTIALITY AGREEMENT:
Any confidential information discussed in this presentation shall be used by the receiving party exclusively for the purposes
of fulfilling the receiving party’s obligation and for no other purpose except with the consent of the disclosing party.
Hemas Investor Relations:
Telephone: +94 11 4 731 731 (Ext. 1278)Email: ir@hemas.comWeb: http://www.hemas.com
Hemas Holdings PLC Hemas House, 75, Braybrooke Place, Colombo 2, Sri Lanka
26